DOTAGA-FAP-2286-ALB Preis auf Anfrage

Artikelnummer: TGM-T207011
Artikelname: DOTAGA-FAP-2286-ALB Preis auf Anfrage
Artikelnummer: TGM-T207011
Hersteller Artikelnummer: T207011
Alternativnummer: TGM-T207011-10MG,TGM-T207011-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
DOTAGA-FAP-2286-ALB is a derivative of Rofapitide tetraxetan. It functions as a selective inhibitor of fibroblast activation protein (FAP) with an IC50 value of 67.5 nM. By interacting with albumin, DOTAGA-FAP-2286-ALB enhances tumor retention, prolongs circulation time in the bloodstream, and improves the stability of radiometal complexes [such as 111In and 225Ac]. This compound shows promise for use in targeted radionuclide therapy (TRT) research for FAP-positive solid tumors.